

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal complex assembly (GO:0007172) | 4.24234963 |
| 2 | regulation of plasminogen activation (GO:0010755) | 4.16901308 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.01649030 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.00544644 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 4.00544644 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.95487158 |
| 7 | synaptic vesicle maturation (GO:0016188) | 3.92214054 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 3.83973213 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.83973213 |
| 10 | neuromuscular process controlling posture (GO:0050884) | 3.64871836 |
| 11 | homocysteine metabolic process (GO:0050667) | 3.63655865 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.52070188 |
| 13 | negative regulation of cell killing (GO:0031342) | 3.52070188 |
| 14 | COPII vesicle coating (GO:0048208) | 3.48968418 |
| 15 | glutamate secretion (GO:0014047) | 3.43423019 |
| 16 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.36821565 |
| 17 | desmosome organization (GO:0002934) | 3.32004590 |
| 18 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.26633083 |
| 19 | negative regulation of cell size (GO:0045792) | 3.26057939 |
| 20 | neuronal action potential propagation (GO:0019227) | 3.22765648 |
| 21 | aromatic amino acid family catabolic process (GO:0009074) | 3.21658123 |
| 22 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.21348124 |
| 23 | kynurenine metabolic process (GO:0070189) | 3.20583880 |
| 24 | amino acid import (GO:0043090) | 3.20298407 |
| 25 | RNA localization (GO:0006403) | 3.17766018 |
| 26 | microtubule nucleation (GO:0007020) | 3.16290835 |
| 27 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.15634051 |
| 28 | positive regulation of nuclease activity (GO:0032075) | 3.15281045 |
| 29 | white fat cell differentiation (GO:0050872) | 3.13847397 |
| 30 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.13729296 |
| 31 | synaptic vesicle exocytosis (GO:0016079) | 3.13127666 |
| 32 | protein retention in ER lumen (GO:0006621) | 3.12836402 |
| 33 | peptidyl-proline hydroxylation (GO:0019511) | 3.10736265 |
| 34 | gamma-aminobutyric acid transport (GO:0015812) | 3.03190914 |
| 35 | positive regulation of protein dephosphorylation (GO:0035307) | 3.01445907 |
| 36 | macroautophagy (GO:0016236) | 3.01426916 |
| 37 | transferrin transport (GO:0033572) | 3.00727457 |
| 38 | 2-oxoglutarate metabolic process (GO:0006103) | 2.98999570 |
| 39 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.97762254 |
| 40 | activation of protein kinase A activity (GO:0034199) | 2.96730999 |
| 41 | regulation of synaptic vesicle transport (GO:1902803) | 2.94981898 |
| 42 | cell communication by electrical coupling (GO:0010644) | 2.94554383 |
| 43 | cysteine metabolic process (GO:0006534) | 2.93790381 |
| 44 | dicarboxylic acid catabolic process (GO:0043649) | 2.92932522 |
| 45 | neurotransmitter secretion (GO:0007269) | 2.90981070 |
| 46 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.89629441 |
| 47 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.89598211 |
| 48 | aspartate family amino acid catabolic process (GO:0009068) | 2.89269390 |
| 49 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.89012918 |
| 50 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.88830941 |
| 51 | vesicle coating (GO:0006901) | 2.87562776 |
| 52 | serine family amino acid catabolic process (GO:0009071) | 2.86492294 |
| 53 | carnitine shuttle (GO:0006853) | 2.86292715 |
| 54 | regulation of cholesterol homeostasis (GO:2000188) | 2.84825830 |
| 55 | detection of calcium ion (GO:0005513) | 2.84014957 |
| 56 | locomotory exploration behavior (GO:0035641) | 2.83931231 |
| 57 | regulation of cholesterol storage (GO:0010885) | 2.83696211 |
| 58 | Golgi transport vesicle coating (GO:0048200) | 2.83204207 |
| 59 | COPI coating of Golgi vesicle (GO:0048205) | 2.83204207 |
| 60 | NADH metabolic process (GO:0006734) | 2.82847573 |
| 61 | biotin metabolic process (GO:0006768) | 2.81089528 |
| 62 | L-amino acid import (GO:0043092) | 2.80892070 |
| 63 | protein localization to endosome (GO:0036010) | 2.80217768 |
| 64 | cellular response to unfolded protein (GO:0034620) | 2.78679458 |
| 65 | chemosensory behavior (GO:0007635) | 2.78004739 |
| 66 | negative regulation of catenin import into nucleus (GO:0035414) | 2.77953084 |
| 67 | glutamate metabolic process (GO:0006536) | 2.77586503 |
| 68 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.76807031 |
| 69 | ferric iron transport (GO:0015682) | 2.75929655 |
| 70 | trivalent inorganic cation transport (GO:0072512) | 2.75929655 |
| 71 | lysine catabolic process (GO:0006554) | 2.75871862 |
| 72 | lysine metabolic process (GO:0006553) | 2.75871862 |
| 73 | regulation of nuclease activity (GO:0032069) | 2.74592869 |
| 74 | tryptophan catabolic process (GO:0006569) | 2.72635116 |
| 75 | indole-containing compound catabolic process (GO:0042436) | 2.72635116 |
| 76 | indolalkylamine catabolic process (GO:0046218) | 2.72635116 |
| 77 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.72031670 |
| 78 | barbed-end actin filament capping (GO:0051016) | 2.72002180 |
| 79 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.70268409 |
| 80 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.68513271 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 2.67388719 |
| 82 | cell communication involved in cardiac conduction (GO:0086065) | 2.66847094 |
| 83 | sodium ion export (GO:0071436) | 2.66025443 |
| 84 | fatty acid transmembrane transport (GO:1902001) | 2.64638047 |
| 85 | alpha-amino acid catabolic process (GO:1901606) | 2.63868838 |
| 86 | cellular response to topologically incorrect protein (GO:0035967) | 2.62833138 |
| 87 | tryptophan metabolic process (GO:0006568) | 2.62008991 |
| 88 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.61479437 |
| 89 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.60397259 |
| 90 | response to pheromone (GO:0019236) | 2.60390739 |
| 91 | cellular amino acid catabolic process (GO:0009063) | 2.60324298 |
| 92 | ER-nucleus signaling pathway (GO:0006984) | 2.59882125 |
| 93 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.57975593 |
| 94 | fructose metabolic process (GO:0006000) | 2.55732906 |
| 95 | vocalization behavior (GO:0071625) | 2.54300674 |
| 96 | alpha-linolenic acid metabolic process (GO:0036109) | 2.53520068 |
| 97 | modulation by virus of host process (GO:0019054) | 2.53285454 |
| 98 | sulfur amino acid catabolic process (GO:0000098) | 2.51301121 |
| 99 | modulation by symbiont of host cellular process (GO:0044068) | 2.49636055 |
| 100 | cellular potassium ion homeostasis (GO:0030007) | 2.49314326 |
| 101 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.48818258 |
| 102 | regulation of synapse structural plasticity (GO:0051823) | 2.48496278 |
| 103 | histone H4-K12 acetylation (GO:0043983) | 2.48375946 |
| 104 | mannose metabolic process (GO:0006013) | 2.47802314 |
| 105 | cellular ketone body metabolic process (GO:0046950) | 2.47568699 |
| 106 | aromatic amino acid family metabolic process (GO:0009072) | 2.47044611 |
| 107 | glycine transport (GO:0015816) | 2.46496235 |
| 108 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.46088786 |
| 109 | fatty acid homeostasis (GO:0055089) | 2.45805386 |
| 110 | response to lipoprotein particle (GO:0055094) | 2.45756418 |
| 111 | oxaloacetate metabolic process (GO:0006107) | 2.45457184 |
| 112 | vesicle targeting (GO:0006903) | 2.45115376 |
| 113 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.44885479 |
| 114 | growth hormone secretion (GO:0030252) | 2.44877537 |
| 115 | branched-chain amino acid catabolic process (GO:0009083) | 2.44863281 |
| 116 | bile acid biosynthetic process (GO:0006699) | 2.44769282 |
| 117 | creatine metabolic process (GO:0006600) | 2.42678328 |
| 118 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.42158788 |
| 119 | regulation of regulated secretory pathway (GO:1903305) | 2.41501270 |
| 120 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.41430110 |
| 121 | amino-acid betaine metabolic process (GO:0006577) | 2.41406972 |
| 122 | protein-chromophore linkage (GO:0018298) | 2.41210516 |
| 123 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.40952918 |
| 124 | cell migration in hindbrain (GO:0021535) | 2.40740270 |
| 125 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.40513329 |
| 126 | mitochondrion degradation (GO:0000422) | 2.40422810 |
| 127 | regulation of autophagic vacuole assembly (GO:2000785) | 2.39578050 |
| 128 | positive regulation of synapse maturation (GO:0090129) | 2.39416373 |
| 129 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.39339775 |
| 130 | glyoxylate metabolic process (GO:0046487) | 2.38063707 |
| 131 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.37256372 |
| 132 | long-term memory (GO:0007616) | 2.37041718 |
| 133 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.35514392 |
| 134 | coenzyme catabolic process (GO:0009109) | 2.35435753 |
| 135 | regulation of ARF protein signal transduction (GO:0032012) | 2.34905230 |
| 136 | positive regulation of membrane potential (GO:0045838) | 2.34819908 |
| 137 | neuromuscular process controlling balance (GO:0050885) | 2.34634083 |
| 138 | positive regulation of protein homooligomerization (GO:0032464) | 2.34467906 |
| 139 | membrane depolarization during action potential (GO:0086010) | 2.34354519 |
| 140 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.33994162 |
| 141 | response to parathyroid hormone (GO:0071107) | 2.33039504 |
| 142 | primary amino compound metabolic process (GO:1901160) | 2.32806706 |
| 143 | short-chain fatty acid metabolic process (GO:0046459) | 2.32221180 |
| 144 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.32091725 |
| 145 | neurotransmitter transport (GO:0006836) | 2.31656674 |
| 146 | protein hydroxylation (GO:0018126) | 2.31636576 |
| 147 | acylglycerol homeostasis (GO:0055090) | 2.31237966 |
| 148 | triglyceride homeostasis (GO:0070328) | 2.31237966 |
| 149 | regulation of bile acid biosynthetic process (GO:0070857) | 2.30597866 |
| 150 | * autophagic vacuole assembly (GO:0000045) | 2.30516347 |
| 151 | positive regulation of sodium ion transport (GO:0010765) | 2.30487445 |
| 152 | L-serine metabolic process (GO:0006563) | 2.30255194 |
| 153 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.29858321 |
| 154 | protein targeting to plasma membrane (GO:0072661) | 2.29613325 |
| 155 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.29569631 |
| 156 | regulation of defense response to virus by virus (GO:0050690) | 2.29479311 |
| 157 | organic acid catabolic process (GO:0016054) | 2.29306696 |
| 158 | carboxylic acid catabolic process (GO:0046395) | 2.29306696 |
| 159 | cerebellar Purkinje cell layer development (GO:0021680) | 2.28605894 |
| 160 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.28251003 |
| 161 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.27212708 |
| 162 | regulation of neurotransmitter levels (GO:0001505) | 2.26974785 |
| 163 | bile acid metabolic process (GO:0008206) | 2.26640423 |
| 164 | 4-hydroxyproline metabolic process (GO:0019471) | 2.26533168 |
| 165 | response to endoplasmic reticulum stress (GO:0034976) | 2.26216789 |
| 166 | fatty acid beta-oxidation (GO:0006635) | 2.25185862 |
| 167 | cerebellar granule cell differentiation (GO:0021707) | 2.24481136 |
| 168 | positive regulation of pseudopodium assembly (GO:0031274) | 2.24270139 |
| 169 | negative regulation of innate immune response (GO:0045824) | 2.24134756 |
| 170 | protein insertion into membrane (GO:0051205) | 2.24089685 |
| 171 | neuronal ion channel clustering (GO:0045161) | 2.23618423 |
| 172 | regulation of gamma-delta T cell activation (GO:0046643) | 2.22854595 |
| 173 | regulation of protein dephosphorylation (GO:0035304) | 2.22854494 |
| 174 | innervation (GO:0060384) | 2.22161630 |
| 175 | megakaryocyte development (GO:0035855) | 2.21117185 |
| 176 | regulation of tight junction assembly (GO:2000810) | 2.17341251 |
| 177 | negative regulation of viral release from host cell (GO:1902187) | 2.16822432 |
| 178 | regulation of superoxide anion generation (GO:0032928) | 2.16536063 |
| 179 | regulation of leukocyte degranulation (GO:0043300) | 2.16253824 |
| 180 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.14340993 |
| 181 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.14340993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.08754311 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.14033351 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.77410996 |
| 4 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.64481617 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.52559363 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.44480870 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.40115756 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.36977247 |
| 9 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.33563654 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.28732408 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.23039347 |
| 12 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.19242055 |
| 13 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.18183800 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.17092442 |
| 15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.13345330 |
| 16 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.13240124 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.08557009 |
| 18 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.05270505 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.04326311 |
| 20 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.98216892 |
| 21 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.94699913 |
| 22 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.92864672 |
| 23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.90589856 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.82133686 |
| 25 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.82039715 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.81132207 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 1.78533651 |
| 28 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.77855090 |
| 29 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74246970 |
| 30 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.67530976 |
| 31 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.66534103 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.65844327 |
| 33 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.64312255 |
| 34 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.63755585 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.63529987 |
| 36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63372610 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.60720915 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.59814419 |
| 39 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.59807601 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57383684 |
| 41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57003946 |
| 42 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.56780188 |
| 43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.47816381 |
| 44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.47203703 |
| 45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44726906 |
| 46 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.43415591 |
| 47 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.42861572 |
| 48 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.42800069 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42699308 |
| 50 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42662732 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42519165 |
| 52 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.42399770 |
| 53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.42088671 |
| 54 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.41222042 |
| 55 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.40105489 |
| 56 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.39259762 |
| 57 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.38874006 |
| 58 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.36161879 |
| 59 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.35923508 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35726071 |
| 61 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.34748300 |
| 62 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.34323731 |
| 63 | P68_20966046_ChIP-Seq_HELA_Human | 1.33668294 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32220606 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32076848 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31592206 |
| 67 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.30613499 |
| 68 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.29813297 |
| 69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29440558 |
| 70 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.29351817 |
| 71 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28679423 |
| 72 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.28310163 |
| 73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.27976036 |
| 74 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.27806525 |
| 75 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.27800973 |
| 76 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.26742823 |
| 77 | UTX_26944678_Chip-Seq_JUKART_Human | 1.25558017 |
| 78 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.25009135 |
| 79 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24126764 |
| 80 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.23754626 |
| 81 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.23487328 |
| 82 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.23245010 |
| 83 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.23245010 |
| 84 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.22396210 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21591469 |
| 86 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.20265413 |
| 87 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.19963349 |
| 88 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.19506152 |
| 89 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.19030601 |
| 90 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18579803 |
| 91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18126494 |
| 92 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.17463554 |
| 93 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17384907 |
| 94 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.17223869 |
| 95 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17182852 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.16764701 |
| 97 | MAF_26560356_Chip-Seq_TH2_Human | 1.16148730 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15852487 |
| 99 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.15067091 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14893058 |
| 101 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14841470 |
| 102 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14482153 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12797913 |
| 104 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.11949502 |
| 105 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10896423 |
| 106 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10338890 |
| 107 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09784300 |
| 108 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09761567 |
| 109 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.09658260 |
| 110 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09051221 |
| 111 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06976150 |
| 112 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06841830 |
| 113 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06265631 |
| 114 | MAF_26560356_Chip-Seq_TH1_Human | 1.04585805 |
| 115 | SA1_27219007_Chip-Seq_Bcells_Human | 1.04547682 |
| 116 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04280713 |
| 117 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.03509316 |
| 118 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.03451001 |
| 119 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.00166390 |
| 120 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.98978559 |
| 121 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98748730 |
| 122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98407288 |
| 123 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.98386331 |
| 124 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.98363766 |
| 125 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.98288614 |
| 126 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.97874879 |
| 127 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.96868428 |
| 128 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95873462 |
| 129 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.93941824 |
| 130 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.93923199 |
| 131 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93655297 |
| 132 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93343645 |
| 133 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.91187868 |
| 134 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.90901995 |
| 135 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.90781280 |
| 136 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.88811805 |
| 137 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.88677431 |
| 138 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87542954 |
| 139 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.87355622 |
| 140 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.85518485 |
| 141 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.84568972 |
| 142 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83584434 |
| 143 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.82567166 |
| 144 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.81998727 |
| 145 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81203519 |
| 146 | AR_19668381_ChIP-Seq_PC3_Human | 0.81039421 |
| 147 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.80636162 |
| 148 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.80398130 |
| 149 | ERA_21632823_ChIP-Seq_H3396_Human | 0.79762215 |
| 150 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.79547015 |
| 151 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.79175810 |
| 152 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.78967060 |
| 153 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.78041204 |
| 154 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.77819960 |
| 155 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.77803591 |
| 156 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.77759536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.88593963 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.70981230 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.64444602 |
| 4 | MP0005365_abnormal_bile_salt | 3.21650478 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.05274863 |
| 6 | MP0003724_increased_susceptibility_to | 2.86332811 |
| 7 | MP0004270_analgesia | 2.80534703 |
| 8 | MP0002822_catalepsy | 2.76093212 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.70963158 |
| 10 | MP0009840_abnormal_foam_cell | 2.60078587 |
| 11 | MP0002909_abnormal_adrenal_gland | 2.58454495 |
| 12 | MP0003436_decreased_susceptibility_to | 2.47597753 |
| 13 | MP0005360_urolithiasis | 2.43530323 |
| 14 | MP0003195_calcinosis | 2.40035306 |
| 15 | MP0003635_abnormal_synaptic_transmissio | 2.36342316 |
| 16 | MP0004043_abnormal_pH_regulation | 2.09907740 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.07491933 |
| 18 | MP0002064_seizures | 2.01308066 |
| 19 | MP0005083_abnormal_biliary_tract | 1.95398307 |
| 20 | MP0000920_abnormal_myelination | 1.93135816 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 1.89189436 |
| 22 | MP0003329_amyloid_beta_deposits | 1.84894606 |
| 23 | MP0009745_abnormal_behavioral_response | 1.79369381 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.78100419 |
| 25 | MP0009046_muscle_twitch | 1.76740535 |
| 26 | MP0002063_abnormal_learning/memory/cond | 1.75425994 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.72845004 |
| 28 | MP0003880_abnormal_central_pattern | 1.71013315 |
| 29 | MP0002272_abnormal_nervous_system | 1.68938397 |
| 30 | MP0002653_abnormal_ependyma_morphology | 1.65037243 |
| 31 | MP0004510_myositis | 1.64835176 |
| 32 | MP0010329_abnormal_lipoprotein_level | 1.64735537 |
| 33 | MP0002132_abnormal_respiratory_system | 1.63759219 |
| 34 | MP0005332_abnormal_amino_acid | 1.62635477 |
| 35 | MP0001666_abnormal_nutrient_absorption | 1.60667717 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.59006829 |
| 37 | MP0003879_abnormal_hair_cell | 1.58113786 |
| 38 | MP0002254_reproductive_system_inflammat | 1.57738815 |
| 39 | MP0008875_abnormal_xenobiotic_pharmacok | 1.54554313 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.54161045 |
| 41 | MP0003075_altered_response_to | 1.52136972 |
| 42 | MP0002734_abnormal_mechanical_nocicepti | 1.46641256 |
| 43 | MP0004947_skin_inflammation | 1.46273652 |
| 44 | MP0002572_abnormal_emotion/affect_behav | 1.45311494 |
| 45 | MP0002736_abnormal_nociception_after | 1.43026906 |
| 46 | MP0002118_abnormal_lipid_homeostasis | 1.42727400 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.41820955 |
| 48 | MP0002733_abnormal_thermal_nociception | 1.39415736 |
| 49 | MP0001661_extended_life_span | 1.38280282 |
| 50 | MP0003283_abnormal_digestive_organ | 1.37723166 |
| 51 | MP0000747_muscle_weakness | 1.37671018 |
| 52 | MP0003252_abnormal_bile_duct | 1.36642755 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.36545663 |
| 54 | MP0008260_abnormal_autophagy | 1.36414795 |
| 55 | MP0002295_abnormal_pulmonary_circulatio | 1.36127189 |
| 56 | MP0004145_abnormal_muscle_electrophysio | 1.35577898 |
| 57 | MP0001486_abnormal_startle_reflex | 1.35445103 |
| 58 | MP0005670_abnormal_white_adipose | 1.35272217 |
| 59 | MP0004233_abnormal_muscle_weight | 1.34421764 |
| 60 | MP0002078_abnormal_glucose_homeostasis | 1.34095468 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.33907975 |
| 62 | MP0002735_abnormal_chemical_nociception | 1.33489667 |
| 63 | MP0003646_muscle_fatigue | 1.32875090 |
| 64 | MP0008961_abnormal_basal_metabolism | 1.32793782 |
| 65 | MP0004885_abnormal_endolymph | 1.31658599 |
| 66 | MP0008995_early_reproductive_senescence | 1.31532896 |
| 67 | MP0005058_abnormal_lysosome_morphology | 1.31522722 |
| 68 | MP0000751_myopathy | 1.31028710 |
| 69 | MP0002089_abnormal_postnatal_growth/wei | 1.29672618 |
| 70 | MP0004858_abnormal_nervous_system | 1.25959941 |
| 71 | MP0001968_abnormal_touch/_nociception | 1.25674942 |
| 72 | MP0009278_abnormal_bone_marrow | 1.25439665 |
| 73 | MP0003634_abnormal_glial_cell | 1.24399553 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 1.24343441 |
| 75 | MP0002693_abnormal_pancreas_physiology | 1.23019632 |
| 76 | MP0004036_abnormal_muscle_relaxation | 1.22886025 |
| 77 | MP0005535_abnormal_body_temperature | 1.22785811 |
| 78 | MP0001970_abnormal_pain_threshold | 1.22678828 |
| 79 | MP0002269_muscular_atrophy | 1.22362690 |
| 80 | MP0008569_lethality_at_weaning | 1.20958912 |
| 81 | MP0001440_abnormal_grooming_behavior | 1.20958071 |
| 82 | MP0002229_neurodegeneration | 1.19863608 |
| 83 | MP0004147_increased_porphyrin_level | 1.17878315 |
| 84 | MP0000013_abnormal_adipose_tissue | 1.17500042 |
| 85 | MP0004185_abnormal_adipocyte_glucose | 1.16281954 |
| 86 | MP0000604_amyloidosis | 1.16270157 |
| 87 | MP0010386_abnormal_urinary_bladder | 1.15398877 |
| 88 | MP0003868_abnormal_feces_composition | 1.14979084 |
| 89 | MP0001502_abnormal_circadian_rhythm | 1.14666723 |
| 90 | MP0004130_abnormal_muscle_cell | 1.12444085 |
| 91 | MP0001944_abnormal_pancreas_morphology | 1.11655889 |
| 92 | MP0002067_abnormal_sensory_capabilities | 1.11392318 |
| 93 | MP0005645_abnormal_hypothalamus_physiol | 1.09358430 |
| 94 | MP0005076_abnormal_cell_differentiation | 1.06851797 |
| 95 | MP0003690_abnormal_glial_cell | 1.06794191 |
| 96 | MP0004924_abnormal_behavior | 1.06210636 |
| 97 | MP0005386_behavior/neurological_phenoty | 1.06210636 |
| 98 | MP0000955_abnormal_spinal_cord | 1.02570979 |
| 99 | MP0002138_abnormal_hepatobiliary_system | 1.02291286 |
| 100 | MP0005451_abnormal_body_composition | 1.01883204 |
| 101 | MP0003566_abnormal_cell_adhesion | 1.01350783 |
| 102 | MP0000749_muscle_degeneration | 1.00313098 |
| 103 | MP0004381_abnormal_hair_follicle | 0.99293035 |
| 104 | MP0002066_abnormal_motor_capabilities/c | 0.98892522 |
| 105 | MP0003953_abnormal_hormone_level | 0.96880682 |
| 106 | MP0003137_abnormal_impulse_conducting | 0.96815615 |
| 107 | MP0000858_altered_metastatic_potential | 0.96620539 |
| 108 | MP0005319_abnormal_enzyme/_coenzyme | 0.95803236 |
| 109 | MP0004084_abnormal_cardiac_muscle | 0.95146043 |
| 110 | MP0004019_abnormal_vitamin_homeostasis | 0.94675600 |
| 111 | MP0003656_abnormal_erythrocyte_physiolo | 0.94480533 |
| 112 | MP0009333_abnormal_splenocyte_physiolog | 0.94202754 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.93719319 |
| 114 | MP0006036_abnormal_mitochondrial_physio | 0.93474124 |
| 115 | MP0003123_paternal_imprinting | 0.93322048 |
| 116 | MP0003633_abnormal_nervous_system | 0.93313385 |
| 117 | MP0001851_eye_inflammation | 0.93304498 |
| 118 | MP0004085_abnormal_heartbeat | 0.93301079 |
| 119 | MP0004811_abnormal_neuron_physiology | 0.92333717 |
| 120 | MP0002069_abnormal_eating/drinking_beha | 0.92325359 |
| 121 | MP0000609_abnormal_liver_physiology | 0.92082487 |
| 122 | MP0008874_decreased_physiological_sensi | 0.89171655 |
| 123 | MP0005220_abnormal_exocrine_pancreas | 0.85400765 |
| 124 | MP0005330_cardiomyopathy | 0.84097032 |
| 125 | MP0001765_abnormal_ion_homeostasis | 0.84031879 |
| 126 | MP0005390_skeleton_phenotype | 0.82677144 |
| 127 | MP0009643_abnormal_urine_homeostasis | 0.82495037 |
| 128 | MP0004215_abnormal_myocardial_fiber | 0.81663139 |
| 129 | MP0001756_abnormal_urination | 0.80891564 |
| 130 | MP0002419_abnormal_innate_immunity | 0.80269225 |
| 131 | MP0003631_nervous_system_phenotype | 0.80177884 |
| 132 | MP0002184_abnormal_innervation | 0.79647019 |
| 133 | MP0005000_abnormal_immune_tolerance | 0.79557952 |
| 134 | MP0001348_abnormal_lacrimal_gland | 0.78425698 |
| 135 | MP0002998_abnormal_bone_remodeling | 0.77785407 |
| 136 | MP0004264_abnormal_extraembryonic_tissu | 0.73802335 |
| 137 | MP0003763_abnormal_thymus_physiology | 0.72611071 |
| 138 | MP0003045_fibrosis | 0.69146315 |
| 139 | MP0001270_distended_abdomen | 0.67444193 |
| 140 | MP0005025_abnormal_response_to | 0.67411146 |
| 141 | MP0003279_aneurysm | 0.65652632 |
| 142 | MP0005164_abnormal_response_to | 0.65178641 |
| 143 | MP0005464_abnormal_platelet_physiology | 0.63615517 |
| 144 | MP0002971_abnormal_brown_adipose | 0.61374474 |
| 145 | MP0003795_abnormal_bone_structure | 0.60160721 |
| 146 | MP0001346_abnormal_lacrimal_gland | 0.58730618 |
| 147 | MP0002163_abnormal_gland_morphology | 0.58181324 |
| 148 | MP0000015_abnormal_ear_pigmentation | 0.56885861 |
| 149 | MP0002970_abnormal_white_adipose | 0.55887040 |
| 150 | MP0003303_peritoneal_inflammation | 0.55109237 |
| 151 | MP0005167_abnormal_blood-brain_barrier | 0.53370568 |
| 152 | MP0003866_abnormal_defecation | 0.53145898 |
| 153 | MP0002876_abnormal_thyroid_physiology | 0.53001056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Spontaneous hematomas (HP:0007420) | 3.95074005 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.84811012 |
| 3 | Gout (HP:0001997) | 3.84532864 |
| 4 | Hyperglycinemia (HP:0002154) | 3.69840147 |
| 5 | Focal motor seizures (HP:0011153) | 3.61682302 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.55865541 |
| 7 | Myokymia (HP:0002411) | 3.55048050 |
| 8 | Hyperglycinuria (HP:0003108) | 3.54834793 |
| 9 | Hypoglycemic coma (HP:0001325) | 3.47695482 |
| 10 | Ketosis (HP:0001946) | 3.35621277 |
| 11 | Ketoacidosis (HP:0001993) | 3.35582557 |
| 12 | Bundle branch block (HP:0011710) | 3.27765256 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 3.16952573 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.16952573 |
| 15 | Visual hallucinations (HP:0002367) | 3.14216982 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.11628667 |
| 17 | Esophageal varix (HP:0002040) | 3.11276241 |
| 18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.93616515 |
| 19 | Hypoglycemic seizures (HP:0002173) | 2.91826434 |
| 20 | Hyperglycemia (HP:0003074) | 2.87844633 |
| 21 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.86225948 |
| 22 | Ventricular fibrillation (HP:0001663) | 2.83066151 |
| 23 | Atrioventricular block (HP:0001678) | 2.83034320 |
| 24 | Insomnia (HP:0100785) | 2.80773547 |
| 25 | Exercise-induced myalgia (HP:0003738) | 2.77891474 |
| 26 | Focal seizures (HP:0007359) | 2.75999972 |
| 27 | Loss of speech (HP:0002371) | 2.75229166 |
| 28 | Hyperammonemia (HP:0001987) | 2.72138680 |
| 29 | Biconcave vertebral bodies (HP:0004586) | 2.71222598 |
| 30 | Obstructive sleep apnea (HP:0002870) | 2.69622249 |
| 31 | Hypercortisolism (HP:0001578) | 2.63317425 |
| 32 | Abnormality of the lower motor neuron (HP:0002366) | 2.63186023 |
| 33 | Distal upper limb amyotrophy (HP:0007149) | 2.61720401 |
| 34 | Upper limb amyotrophy (HP:0009129) | 2.61720401 |
| 35 | Cerebral inclusion bodies (HP:0100314) | 2.60600945 |
| 36 | Hand muscle atrophy (HP:0009130) | 2.60046890 |
| 37 | Hyperlipoproteinemia (HP:0010980) | 2.59435493 |
| 38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.59247948 |
| 39 | Abnormality of glycolipid metabolism (HP:0010969) | 2.59247948 |
| 40 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.59247948 |
| 41 | Gastrointestinal dysmotility (HP:0002579) | 2.58122342 |
| 42 | Status epilepticus (HP:0002133) | 2.56081519 |
| 43 | Heart block (HP:0012722) | 2.55722821 |
| 44 | Supranuclear gaze palsy (HP:0000605) | 2.55392144 |
| 45 | Myocardial infarction (HP:0001658) | 2.54850886 |
| 46 | Ileus (HP:0002595) | 2.54263543 |
| 47 | Clonus (HP:0002169) | 2.51139749 |
| 48 | Xanthomatosis (HP:0000991) | 2.48735199 |
| 49 | Heterochromia iridis (HP:0001100) | 2.46501401 |
| 50 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.46339974 |
| 51 | Single umbilical artery (HP:0001195) | 2.46339974 |
| 52 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.46339974 |
| 53 | Generalized tonic-clonic seizures (HP:0002069) | 2.45461049 |
| 54 | Symptomatic seizures (HP:0011145) | 2.45283760 |
| 55 | Epileptic encephalopathy (HP:0200134) | 2.44924199 |
| 56 | Abnormal social behavior (HP:0012433) | 2.39763250 |
| 57 | Impaired social interactions (HP:0000735) | 2.39763250 |
| 58 | Visceral angiomatosis (HP:0100761) | 2.38607142 |
| 59 | Anorexia (HP:0002039) | 2.36398533 |
| 60 | Testicular atrophy (HP:0000029) | 2.35813067 |
| 61 | Oligomenorrhea (HP:0000876) | 2.35361668 |
| 62 | Late onset (HP:0003584) | 2.32675395 |
| 63 | Abnormality of binocular vision (HP:0011514) | 2.32596477 |
| 64 | Diplopia (HP:0000651) | 2.32596477 |
| 65 | Deep venous thrombosis (HP:0002625) | 2.32119870 |
| 66 | Cholecystitis (HP:0001082) | 2.30291145 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 2.30291145 |
| 68 | Neurofibrillary tangles (HP:0002185) | 2.29934589 |
| 69 | Abnormal atrioventricular conduction (HP:0005150) | 2.29790001 |
| 70 | Growth hormone excess (HP:0000845) | 2.28531251 |
| 71 | Pheochromocytoma (HP:0002666) | 2.26381831 |
| 72 | Back pain (HP:0003418) | 2.26189582 |
| 73 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.26140604 |
| 74 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.25360840 |
| 75 | Poor eye contact (HP:0000817) | 2.21348456 |
| 76 | Peripheral hypomyelination (HP:0007182) | 2.21221656 |
| 77 | Sudden death (HP:0001699) | 2.20801671 |
| 78 | Neuronal loss in central nervous system (HP:0002529) | 2.17860345 |
| 79 | Myoglobinuria (HP:0002913) | 2.17016719 |
| 80 | Large for gestational age (HP:0001520) | 2.16688307 |
| 81 | Hyperparathyroidism (HP:0000843) | 2.16319209 |
| 82 | Slow saccadic eye movements (HP:0000514) | 2.15963928 |
| 83 | Polygenic inheritance (HP:0010982) | 2.14336791 |
| 84 | Tetraplegia (HP:0002445) | 2.14287620 |
| 85 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.12900402 |
| 86 | Abnormality of the intrinsic pathway (HP:0010989) | 2.12749200 |
| 87 | EEG with generalized epileptiform discharges (HP:0011198) | 2.11604920 |
| 88 | Dysostosis multiplex (HP:0000943) | 2.10566790 |
| 89 | Complement deficiency (HP:0004431) | 2.09798022 |
| 90 | Absence seizures (HP:0002121) | 2.09727585 |
| 91 | Spinal canal stenosis (HP:0003416) | 2.09648757 |
| 92 | Vertebral compression fractures (HP:0002953) | 2.09636830 |
| 93 | Ankle clonus (HP:0011448) | 2.09162569 |
| 94 | Dialeptic seizures (HP:0011146) | 2.09108586 |
| 95 | Pulmonary embolism (HP:0002204) | 2.08912196 |
| 96 | Pustule (HP:0200039) | 2.07955700 |
| 97 | Epileptiform EEG discharges (HP:0011182) | 2.07922991 |
| 98 | Cerebral hypomyelination (HP:0006808) | 2.06126073 |
| 99 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.05480623 |
| 100 | Hypsarrhythmia (HP:0002521) | 2.04859571 |
| 101 | Syncope (HP:0001279) | 2.04012783 |
| 102 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.02832249 |
| 103 | Dicarboxylic aciduria (HP:0003215) | 2.02832249 |
| 104 | Hemangiomatosis (HP:0007461) | 2.02031657 |
| 105 | Global brain atrophy (HP:0002283) | 2.01990682 |
| 106 | Abnormality of serum amino acid levels (HP:0003112) | 2.01647400 |
| 107 | Atonic seizures (HP:0010819) | 2.01141262 |
| 108 | Abnormal gallbladder morphology (HP:0012437) | 2.01105876 |
| 109 | Hyporeflexia of lower limbs (HP:0002600) | 2.01051014 |
| 110 | Myopathic facies (HP:0002058) | 1.99937225 |
| 111 | Postural instability (HP:0002172) | 1.99566184 |
| 112 | Fatigue (HP:0012378) | 1.99516295 |
| 113 | Progressive cerebellar ataxia (HP:0002073) | 1.99210668 |
| 114 | Febrile seizures (HP:0002373) | 1.97927706 |
| 115 | Action tremor (HP:0002345) | 1.97545472 |
| 116 | Conjugated hyperbilirubinemia (HP:0002908) | 1.95971728 |
| 117 | Myositis (HP:0100614) | 1.95534846 |
| 118 | Spastic gait (HP:0002064) | 1.94817471 |
| 119 | Prolonged partial thromboplastin time (HP:0003645) | 1.94246715 |
| 120 | Depression (HP:0000716) | 1.94177531 |
| 121 | Eczematoid dermatitis (HP:0000976) | 1.93830811 |
| 122 | Delusions (HP:0000746) | 1.93716461 |
| 123 | Ventricular arrhythmia (HP:0004308) | 1.93630704 |
| 124 | Increased purine levels (HP:0004368) | 1.92908139 |
| 125 | Hyperuricemia (HP:0002149) | 1.92908139 |
| 126 | Dysmetric saccades (HP:0000641) | 1.92800989 |
| 127 | Cholelithiasis (HP:0001081) | 1.92325653 |
| 128 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.90887815 |
| 129 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.90887815 |
| 130 | Anxiety (HP:0000739) | 1.90745572 |
| 131 | Systemic lupus erythematosus (HP:0002725) | 1.90692476 |
| 132 | Neuroendocrine neoplasm (HP:0100634) | 1.89626615 |
| 133 | Irritability (HP:0000737) | 1.89527319 |
| 134 | Hypoalphalipoproteinemia (HP:0003233) | 1.89299689 |
| 135 | Palpitations (HP:0001962) | 1.88140045 |
| 136 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.87928930 |
| 137 | Progressive muscle weakness (HP:0003323) | 1.87336577 |
| 138 | Skin nodule (HP:0200036) | 1.87154043 |
| 139 | Resting tremor (HP:0002322) | 1.87095289 |
| 140 | Abnormality of purine metabolism (HP:0004352) | 1.86672500 |
| 141 | Truncal ataxia (HP:0002078) | 1.86195731 |
| 142 | Hyperacusis (HP:0010780) | 1.85758433 |
| 143 | Small epiphyses (HP:0010585) | 1.85134096 |
| 144 | Abnormality of alanine metabolism (HP:0010916) | 1.84464677 |
| 145 | Hyperalaninemia (HP:0003348) | 1.84464677 |
| 146 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.84464677 |
| 147 | Intention tremor (HP:0002080) | 1.84231689 |
| 148 | Death in childhood (HP:0003819) | 1.83857867 |
| 149 | Glomerulonephritis (HP:0000099) | 1.83549195 |
| 150 | Mitral stenosis (HP:0001718) | 1.83380570 |
| 151 | Dysmetria (HP:0001310) | 1.83085277 |
| 152 | Torticollis (HP:0000473) | 1.82960798 |
| 153 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.82364805 |
| 154 | Generalized aminoaciduria (HP:0002909) | 1.82080457 |
| 155 | Gingival bleeding (HP:0000225) | 1.81760279 |
| 156 | Mucopolysacchariduria (HP:0008155) | 1.81695041 |
| 157 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81695041 |
| 158 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81458214 |
| 159 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81458214 |
| 160 | Hypercalciuria (HP:0002150) | 1.80856735 |
| 161 | Disproportionate tall stature (HP:0001519) | 1.80781591 |
| 162 | Poor speech (HP:0002465) | 1.79053710 |
| 163 | Microcytic anemia (HP:0001935) | 1.75382458 |
| 164 | Abnormality of the umbilical cord (HP:0010881) | 1.72628292 |
| 165 | Dementia (HP:0000726) | 1.72314098 |
| 166 | Urinary incontinence (HP:0000020) | 1.72068028 |
| 167 | Congenital sensorineural hearing impairment (HP:0008527) | 1.68259647 |
| 168 | Insulin resistance (HP:0000855) | 1.68211476 |
| 169 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.66492522 |
| 170 | Osteoarthritis (HP:0002758) | 1.66325674 |
| 171 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.66036404 |
| 172 | Reticulocytosis (HP:0001923) | 1.65221963 |
| 173 | Hammertoe (HP:0001765) | 1.65033958 |
| 174 | Elevated alkaline phosphatase (HP:0003155) | 1.64979620 |
| 175 | White forelock (HP:0002211) | 1.64781593 |
| 176 | Recurrent abscess formation (HP:0002722) | 1.64351158 |
| 177 | Cortical visual impairment (HP:0100704) | 1.63575609 |
| 178 | Increased cerebral lipofuscin (HP:0011813) | 1.62621900 |
| 179 | Rigidity (HP:0002063) | 1.62570828 |
| 180 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.62002851 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.46081968 |
| 2 | AKT3 | 3.34302170 |
| 3 | LMTK2 | 3.03098847 |
| 4 | MAP3K9 | 2.94056663 |
| 5 | EPHA4 | 2.76369861 |
| 6 | BCKDK | 2.76208421 |
| 7 | PRPF4B | 2.70554088 |
| 8 | MAP3K3 | 2.37692585 |
| 9 | INSRR | 2.36337177 |
| 10 | ERN1 | 2.29129640 |
| 11 | PAK6 | 2.24923322 |
| 12 | MAP2K3 | 2.22696371 |
| 13 | NTRK1 | 2.20050122 |
| 14 | PINK1 | 2.08112182 |
| 15 | DAPK2 | 2.03794036 |
| 16 | RIPK4 | 1.94314021 |
| 17 | PRKD3 | 1.81134915 |
| 18 | KSR2 | 1.76163214 |
| 19 | STK38 | 1.72611391 |
| 20 | CAMKK2 | 1.72595966 |
| 21 | SMG1 | 1.69230412 |
| 22 | CAMKK1 | 1.68816261 |
| 23 | MAP2K4 | 1.65302932 |
| 24 | IRAK3 | 1.60331668 |
| 25 | SIK3 | 1.57979827 |
| 26 | MAP3K4 | 1.55551760 |
| 27 | PRKD2 | 1.51345068 |
| 28 | MAP4K1 | 1.51064863 |
| 29 | ICK | 1.49388717 |
| 30 | TESK1 | 1.46850127 |
| 31 | FGR | 1.46120613 |
| 32 | TAOK3 | 1.44319339 |
| 33 | SIK1 | 1.44258136 |
| 34 | PHKG1 | 1.42835699 |
| 35 | PHKG2 | 1.42835699 |
| 36 | ARAF | 1.42687439 |
| 37 | EPHA2 | 1.35296737 |
| 38 | MAP3K2 | 1.33622248 |
| 39 | LIMK1 | 1.33499733 |
| 40 | NEK1 | 1.33122404 |
| 41 | SGK223 | 1.32652982 |
| 42 | SGK494 | 1.32652982 |
| 43 | GRK6 | 1.26716490 |
| 44 | MAP3K1 | 1.24369610 |
| 45 | TAOK1 | 1.23805530 |
| 46 | SGK3 | 1.22382412 |
| 47 | MINK1 | 1.21847787 |
| 48 | DYRK1B | 1.19169362 |
| 49 | CDK9 | 1.16605673 |
| 50 | TRIB3 | 1.13036048 |
| 51 | GRK5 | 1.11835790 |
| 52 | CDC42BPA | 1.06027284 |
| 53 | MARK1 | 1.05768408 |
| 54 | FES | 1.05244138 |
| 55 | PDPK1 | 1.03069178 |
| 56 | SGK2 | 1.01643732 |
| 57 | CDK5 | 0.98924703 |
| 58 | ALK | 0.96702351 |
| 59 | PRKCG | 0.95357333 |
| 60 | PRKCI | 0.95284304 |
| 61 | EPHA3 | 0.95105424 |
| 62 | PRKCH | 0.94010793 |
| 63 | PAK3 | 0.93878215 |
| 64 | CAMK2G | 0.93873483 |
| 65 | FGFR4 | 0.93672708 |
| 66 | ZAP70 | 0.93586866 |
| 67 | NEK6 | 0.93155078 |
| 68 | JAK3 | 0.92234318 |
| 69 | PTK6 | 0.88288796 |
| 70 | TAOK2 | 0.87846637 |
| 71 | TYRO3 | 0.86680450 |
| 72 | CAMK1 | 0.86580033 |
| 73 | PDGFRA | 0.84024661 |
| 74 | IRAK2 | 0.83305743 |
| 75 | MAPK15 | 0.82867375 |
| 76 | CAMK2D | 0.80919256 |
| 77 | TESK2 | 0.79097815 |
| 78 | BRAF | 0.78241814 |
| 79 | PDK1 | 0.77255603 |
| 80 | DAPK1 | 0.76393470 |
| 81 | PRKAA1 | 0.74582054 |
| 82 | HIPK2 | 0.74154879 |
| 83 | SIK2 | 0.73998448 |
| 84 | RIPK1 | 0.73607097 |
| 85 | PNCK | 0.73281488 |
| 86 | PIM2 | 0.72629412 |
| 87 | CAMK4 | 0.71881513 |
| 88 | RET | 0.70412703 |
| 89 | WNK1 | 0.70238531 |
| 90 | WNK4 | 0.69566543 |
| 91 | PDK4 | 0.67691890 |
| 92 | PDK3 | 0.67691890 |
| 93 | UHMK1 | 0.66524355 |
| 94 | PRKG2 | 0.66419100 |
| 95 | MAP2K7 | 0.66405884 |
| 96 | IRAK4 | 0.66239189 |
| 97 | MAPK11 | 0.66221106 |
| 98 | CAMK2B | 0.66178095 |
| 99 | MAPKAPK3 | 0.65459689 |
| 100 | PAK4 | 0.65456517 |
| 101 | JAK2 | 0.62332771 |
| 102 | NTRK2 | 0.61849900 |
| 103 | TBK1 | 0.61060754 |
| 104 | CLK1 | 0.61058653 |
| 105 | BMPR2 | 0.61042732 |
| 106 | MTOR | 0.60499858 |
| 107 | EEF2K | 0.60319364 |
| 108 | STK11 | 0.60112894 |
| 109 | MARK2 | 0.59869830 |
| 110 | CAMK1G | 0.59199707 |
| 111 | CAMK2A | 0.57396150 |
| 112 | JAK1 | 0.56804386 |
| 113 | MAP3K11 | 0.55210806 |
| 114 | YES1 | 0.55165759 |
| 115 | KSR1 | 0.54762025 |
| 116 | PRKACG | 0.53956708 |
| 117 | BMX | 0.53941147 |
| 118 | PRKD1 | 0.53832144 |
| 119 | MAPK10 | 0.53088129 |
| 120 | FER | 0.52935515 |
| 121 | PKN1 | 0.52858677 |
| 122 | MAP2K1 | 0.52229749 |
| 123 | TNK2 | 0.52155937 |
| 124 | CDK12 | 0.51885170 |
| 125 | CDK19 | 0.51519506 |
| 126 | EPHB1 | 0.50148130 |
| 127 | DAPK3 | 0.49789883 |
| 128 | OXSR1 | 0.49558429 |
| 129 | CAMK1D | 0.48808969 |
| 130 | MAP3K7 | 0.47811017 |
| 131 | RPS6KA3 | 0.47618342 |
| 132 | SGK1 | 0.47274931 |
| 133 | MAPK7 | 0.46765845 |
| 134 | MAPKAPK2 | 0.44668318 |
| 135 | BRSK1 | 0.44606253 |
| 136 | MAP2K2 | 0.44300229 |
| 137 | PRKCZ | 0.42809313 |
| 138 | FLT3 | 0.42575508 |
| 139 | PTK2 | 0.42500363 |
| 140 | RPS6KA2 | 0.42007992 |
| 141 | MAPK12 | 0.40851601 |
| 142 | FYN | 0.39385107 |
| 143 | PRKCD | 0.35516904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.18142702 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.92560743 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.69044595 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.33683461 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.27357514 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.23532232 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.13428855 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.11751464 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.00139889 |
| 10 | Insulin secretion_Homo sapiens_hsa04911 | 1.89554111 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.86843696 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.82173519 |
| 13 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75395516 |
| 14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.73901123 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.68640302 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.64096207 |
| 17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.60065089 |
| 18 | GABAergic synapse_Homo sapiens_hsa04727 | 1.53690191 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.50304811 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.49769902 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.42348098 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.36821867 |
| 23 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.34556001 |
| 24 | Nicotine addiction_Homo sapiens_hsa05033 | 1.32195511 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.31117549 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30034818 |
| 27 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.29875026 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.29403392 |
| 29 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.28624576 |
| 30 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.27794139 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.22277500 |
| 32 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.22145657 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.21642101 |
| 34 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.21505372 |
| 35 | Circadian entrainment_Homo sapiens_hsa04713 | 1.21281586 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.21017309 |
| 37 | Taste transduction_Homo sapiens_hsa04742 | 1.19567391 |
| 38 | Endocytosis_Homo sapiens_hsa04144 | 1.18919836 |
| 39 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.18028061 |
| 40 | * Regulation of autophagy_Homo sapiens_hsa04140 | 1.17764829 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.17111613 |
| 42 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.15565665 |
| 43 | Glioma_Homo sapiens_hsa05214 | 1.13914979 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13883979 |
| 45 | Olfactory transduction_Homo sapiens_hsa04740 | 1.13023732 |
| 46 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.10491639 |
| 47 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.10166860 |
| 48 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.10093250 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.09212002 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.08435292 |
| 51 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.06944655 |
| 52 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.06912379 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06387038 |
| 54 | Long-term potentiation_Homo sapiens_hsa04720 | 1.04685348 |
| 55 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.04647558 |
| 56 | Circadian rhythm_Homo sapiens_hsa04710 | 1.04590172 |
| 57 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.04096810 |
| 58 | Thyroid cancer_Homo sapiens_hsa05216 | 1.02682947 |
| 59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02067841 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.02043914 |
| 61 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99761389 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99480957 |
| 63 | Peroxisome_Homo sapiens_hsa04146 | 0.99164991 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.98875767 |
| 65 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.98850126 |
| 66 | Morphine addiction_Homo sapiens_hsa05032 | 0.98558942 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.97063295 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.96262752 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95946218 |
| 70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.95741083 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.94284617 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.93942821 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93844326 |
| 74 | Cocaine addiction_Homo sapiens_hsa05030 | 0.92018017 |
| 75 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.91985233 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91914134 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91693665 |
| 78 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.91260437 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.90097724 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.89308298 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88177571 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87080567 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85858892 |
| 84 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.85692666 |
| 85 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.85352943 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.82976750 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82745192 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82437053 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.82033342 |
| 90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81321326 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80269586 |
| 92 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78713908 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77827042 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77456421 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77073343 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76705464 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.76661152 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74852976 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74731790 |
| 100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.74257903 |
| 101 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74199660 |
| 102 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.74160107 |
| 103 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73597129 |
| 104 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.73529964 |
| 105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73311307 |
| 106 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.73232782 |
| 107 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.73177482 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.73095925 |
| 109 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.72116036 |
| 110 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71929525 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71331685 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70191956 |
| 113 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.69995784 |
| 114 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.69624279 |
| 115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.69350529 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68708647 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68385344 |
| 118 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.67801939 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.67256119 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65595292 |
| 121 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.60372572 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59606989 |
| 123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59005349 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.58807846 |
| 125 | Hepatitis C_Homo sapiens_hsa05160 | 0.57743198 |
| 126 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57697840 |
| 127 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.57441801 |
| 128 | Shigellosis_Homo sapiens_hsa05131 | 0.57275246 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57050830 |
| 130 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56838871 |
| 131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56402672 |
| 132 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55153634 |
| 133 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54257856 |
| 134 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52276256 |
| 135 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51546021 |
| 136 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51434535 |
| 137 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51356116 |
| 138 | Apoptosis_Homo sapiens_hsa04210 | 0.51217175 |
| 139 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.51109104 |
| 140 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50997443 |
| 141 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50743844 |
| 142 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50542025 |
| 143 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50140529 |
| 144 | Lysine degradation_Homo sapiens_hsa00310 | 0.49851446 |
| 145 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49158505 |
| 146 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48924272 |
| 147 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48221744 |
| 148 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48138512 |
| 149 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46337966 |
| 150 | Bladder cancer_Homo sapiens_hsa05219 | 0.46256192 |
| 151 | Axon guidance_Homo sapiens_hsa04360 | 0.45109835 |
| 152 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44783364 |
| 153 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44613659 |
| 154 | Renin secretion_Homo sapiens_hsa04924 | 0.44292950 |

